Zuellig Pharma Unveils State-of-the-Art Clinical Trial Support Innovation Center in South Korea to Support Both Domestic and Global Clinical Research Needs
Gyeonggi-do, South Korea--(Newsfile Corp. - November 30, 2025) - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced the grand opening of its new state-of-the-art Clinical Trial Support (CTS) Innovation Center in South Korea. The opening of this facility underscores Zuellig Pharma's continued investment and commitment to advancing healthcare, reinforcing its position as a trusted regional partner in driving meaningful outcomes for patients,...
http://dlvr.it/TPYC0M
http://dlvr.it/TPYC0M
Comments
Post a Comment